Process Systems Engineering in Precision Medicine: Opportunities in Autologous CAR-T Therapy. [PDF]
Wayne Bequette B.
europepmc +1 more source
Dual anti-CD19/22 and anti-BCMA CAR T-cell therapy in a patient with multiple myeloma and secondary B-ALL. [PDF]
Roerden M +10 more
europepmc +1 more source
Axicabtagene ciloleucel CAR T-cell therapy in refractory large B-Cell lymphoma [PDF]
Bartlett, N. L, et al,, Ghobadi, A.
core +1 more source
Real-world outcomes of brexucabtagene autoleucel for relapsed or refractory mantle cell lymphoma: a CIBMTR analysis. [PDF]
Ahmed N +26 more
europepmc +1 more source
Thrombophilia screening of related hematopoietic stem cell donors before collection: results of a single-center activity. [PDF]
Crocchiolo R +10 more
europepmc +1 more source
Zamtocabtagene autoleucel in relapsed/refractory B-NHL: 5-year follow-up of a CD20/19 tandem CAR T-cell phase 1 trial. [PDF]
Balke-Want H +22 more
europepmc +1 more source
Management of Leukostasis in Acute Myeloid Leukemia. [PDF]
Pais KL, Spring J, Hayes MM.
europepmc +1 more source
An Incredible Impact of Antibiotics on Leukostasis. [PDF]
Chimauriya R +3 more
europepmc +1 more source
CAR T cells and T cell engagers for autoimmunity-lessons from hematology. [PDF]
Kayser S, Nagler A.
europepmc +1 more source

